David A. Jr. and Ky Jones Reap Financial Benefits by Selling 15,000 Shares of Humana

December 30, 2022

Categories: Intrinsic ValueTags: , , Views: 106

Trending News ☀️

Humana Inc Stock Fair Value – Humana Inc ($NYSE:HUM). is one of the largest health insurance companies in the United States. It has a wide range of products and services such as Medicare Advantage plans, prescription drug plans, and Medicaid plans. This move is seen as a financial gain for the two shareholders as it is expected to bring them significant returns by way of profits or dividends. The two shareholders have been holding on to their shares for quite some time.

The sale of these 15,000 shares marks the first major move they have made in regards to Humana Inc. stock in over three years. While the move may be seen as a financial gain for the two shareholders, it could also be seen as an indication of their confidence in the company’s future prospects. Some believe that the move was done out of financial necessity, while others view it as a sign that the two shareholders have faith in Humana Inc.’s ability to perform well in the future. Regardless, the sale has been seen as beneficial for the two shareholders as it has allowed them to reap financial benefits from their investment in Humana Inc.

Market Price

The media sentiment towards Humana Inc has been mostly positive till now. On the same day, the stock opened at $515.7 and closed at $514.4, a mere 0.1% increase from the last closing price of $514.0. These two investors have made a wise decision in selling off their shares in Humana Inc as the stock has been on a steady rise since mid-August this year. The two investors have been able to capitalize on Humana Inc’s positive momentum in the market and thus, have reaped financial benefits from their decision to sell their stocks.

This decision could prove to be a profitable one as the company continues to perform well in the market, despite the current economic situation. The company has seen a steady growth in its stock prices over the past few months, which indicates that investors have faith in the company’s success. This decision has enabled them to reap financial benefits from their investments and could prove to be a profitable move in the long run if the company continues to perform well in the market. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Humana Inc. More…

    Total Revenues Net Income Net Margin
    91.48k 2.81k 2.9%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Humana Inc. More…

    Operations Investing Financing
    9.62k -96 -268
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Humana Inc. More…

    Total Assets Total Liabilities Book Value Per Share
    50.77k 34.45k 128.39
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Humana Inc are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    13.4% 4.3%
    FCF Margin ROE ROA
    9.2% 15.6% 4.9%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items


  • VI Analysis – Humana Inc Stock Fair Value Calculator

    HUMANA INC is a company whose fundamentals reflect its long-term potential. This can be seen through analysis made simple by the VI app. According to the VI Line, the fair value of HUMANA INC’s share is approximately $492.3. At present, the stock is being traded at $514.4, leaving it with a fair price that is overvalued by 4%. The company has posted strong earnings in recent quarters, and its growth prospects remain positive. Its balance sheet is also strong, with plenty of cash and low levels of debt. In addition, HUMANA INC is well diversified across multiple sectors, giving it greater stability and resiliency. The company also has a relatively low P/E ratio, indicating that it is currently trading at a discount compared to its peers. Overall, HUMANA INC appears to be a sound investment opportunity that offers investors a chance to benefit from the company’s long-term potential. Its fundamentals are strong, and its current trading price is slightly overvalued. Investors looking for a safe and secure long-term investment may want to take advantage of this opportunity. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis
  • VI Peers

    In the ever-changing world of healthcare, Humana Inc. has been a leader in providing quality services to its customers. However, the company faces stiff competition from the likes of UnitedHealth Group Inc, Cigna Corp, and Oscar Health Inc. All of these companies are striving to provide the best possible healthcare experience to their customers.

    – UnitedHealth Group Inc ($NYSE:UNH)

    UnitedHealth Group Inc. is an American for-profit managed health care company based in Minnetonka, Minnesota. It is the largest healthcare company in the world by revenue, with 2019 revenue of $242.2 billion. The company offers health care products and services through two operating businesses: UnitedHealthcare and Optum.

    UnitedHealthcare provides health benefits and services to individuals, families, and businesses through a wide array of plans and programs, including health insurance, pharmacy benefits, vision, dental, and other supplemental health and wellness benefits. Optum is a health services and innovation company that provides technology-enabled health services and software. It offers healthcare information technology, data analytics, and research and consulting services to the healthcare industry.

    The company has a market capitalization of $488.16 billion as of April 2021 and a return on equity of 21.75%.

    – Cigna Corp ($NYSE:CI)

    Cigna Corp is a health services company with a market cap of 88.46 billion as of 2022. The company has a return on equity of 11.01%. Cigna Corp provides medical, dental, disability, life, and other health insurance products and services. The company also offers pharmacy benefit management services.

    – Oscar Health Inc ($NYSE:OSCR)

    Oscar Health is a technology-driven health insurance company founded in 2012. The company’s mission is to make health insurance simple, transparent, and human.

    Oscar uses technology to simplify the health insurance experience for consumers and providers. The company has a suite of tools that helps consumers understand their benefits, find doctors, and estimate the cost of care. For providers, Oscar offers a platform that streamlines claims processing and provides real-time insights into patients’ health insurance benefits.

    Oscar Health is headquartered in New York City and is available in nine states: California, Colorado, Florida, Georgia, Illinois, Michigan, New Jersey, New York, and Texas.

    Summary

    Investing in Humana Inc. has been a financially beneficial endeavor for David A. Jr. and Ky Jones, who recently sold 15,000 shares of the company for a profit. The market sentiment for Humana Inc. has largely been positive, with analysts citing a bright future for the healthcare provider. If interested in investing, potential investors should consider the company’s history of stock performance, its financials, and industry trends before investing. Additionally, investors should research Humana Inc.’s competitive advantages, such as its customer service and its innovative healthcare solutions, to better understand the company’s current and future prospects.

    Recent Posts

    Leave a Comment